Published in Ther Drug Monit on March 01, 1990
Chirality and drugs used in psychiatry: nice to know or need to know? Cell Mol Neurobiol (1999) 0.92
Prediction of steady-state plasma levels of doxepin and imipramine from single dose levels in depressed outpatients. J Psychiatry Neurosci (1991) 0.75
Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am J Med Genet (2000) 3.05
Review of influenza A virus in swine worldwide: a call for increased surveillance and research. Zoonoses Public Health (2013) 1.67
Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy. Eur Neuropsychopharmacol (1998) 1.51
Therapeutic efficacy of specific serotonin reuptake inhibitors (SSRIs) in dysthymia. Can J Psychiatry (1994) 1.48
Thyrotropin releasing hormone potentiates the effects of imipramine on brain serotonergic system. Brain Res Bull (1981) 1.39
Treatment of major affective disorder with fluvoxamine. J Clin Psychiatry (1987) 1.06
A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial. Acta Psychiatr Scand Suppl (1990) 1.05
Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims. Biol Psychiatry (1999) 1.03
Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population. J Infect Dis (1991) 1.01
Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study. Synapse (1993) 0.98
Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors. J Psychiatry Neurosci (1995) 0.97
Quantitative EEG in the prediction of antidepressant response to imipramine. J Affect Disord (1996) 0.97
Direct observation of UV-crosslinked protein-nucleic acid complexes by matrix-assisted laser desorption ionization mass spectrometry. Rapid Commun Mass Spectrom (1993) 0.97
Gender differences in association between serotonin transporter gene polymorphism and personality traits. Psychiatr Genet (2000) 0.95
Low temperature sustains inhibition of angiotensin-converting-enzyme activity in serum from patients taking captopril. N Engl J Med (1981) 0.93
A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis. J Clin Psychiatry (1982) 0.92
An examination of the sensitivity of the six-item Hamilton Rating Scale for Depression in a sample of patients suffering from major depressive disorder. J Psychiatry Neurosci (2000) 0.92
Retention rates in placebo- and nonplacebo-controlled clinical trials of schizophrenia. Can J Psychiatry (1999) 0.90
Benzodiazepine withdrawal. Can J Psychiatry (1981) 0.89
Evidence for the role of brain norepinephrine and dopamine in "rebound" phenomenon seen during withdrawal after repeated exposure to benzodiazepines. J Psychiatr Res (1977) 0.88
Koro in a French Canadian. Can Psychiatr Assoc J (1972) 0.88
Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment. Psychiatry Res (1997) 0.87
Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression. Psychiatry Res (1999) 0.86
A comparison of placebo responders and nonresponders in subgroups of depressive disorder. J Psychiatry Neurosci (1995) 0.86
Are all benzodiazepines clinically equivalent? Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.86
Three-dimensional structure of fibrolase, the fibrinolytic enzyme from southern copperhead venom, modeled from the X-ray structure of adamalysin II and atrolysin C. AAPS PharmSci (2001) 0.85
Gas--liquid chromatographic determination of pipotiazine in plasma of psychiatric patients. J Chromatogr (1981) 0.85
Thymidylate synthase inhibitors. Semin Oncol (1999) 0.85
Diazepam and benzoctamlne: effects on certain objective parameters of muscular spasticity. Curr Ther Res Clin Exp (1973) 0.85
Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride. The Canadian Remoxipride Group. J Psychiatry Neurosci (1997) 0.83
Serotonergic genes and suicidality. Crisis (2001) 0.83
Modelling the cost effectiveness of antidepressant treatment in primary care. Pharmacoeconomics (1995) 0.83
A Canadian multicenter study of three fixed doses of controlled-release ipsapirone in outpatients with moderate to severe major depression. J Clin Psychopharmacol (1998) 0.83
Whole body leucine, phenylalanine, and tyrosine kinetics in end-stage liver disease before and after hepatic transplantation. Metabolism (1987) 0.83
Lelystad-like strain of porcine reproductive and respiratory syndrome virus (PRRSV) identified in Canadian swine. Can Vet J (2000) 0.83
Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial. Psychol Med (2008) 0.82
New tools, new dilemmas: genetic frontiers. Hastings Cent Rep (1989) 0.82
Computerized EEG correlates of depression and antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry (1987) 0.82
Transmission of HTLV-II via blood transfusion. Vox Sang (1990) 0.82
Some neurochemical correlates of "rebound" phenomenon observed during withdrawal after long-term exposure to 1, 4-benzodiazepines. Prog Neuropsychopharmacol (1978) 0.82
Effective treatment of mania with olanzapine: 2 case reports. J Psychiatry Neurosci (1997) 0.82
Tryptophan hydroxylase gene 218A/C polymorphism is associated with somatic anxiety in major depressive disorder. J Affect Disord (2001) 0.82
Fluphenazine, trifluoperazine and perphenazine in Vacutainers. Can Med Assoc J (1981) 0.82
Reduction in suicidal ideation with SSRIs: a review of 459 depressed patients. J Psychiatry Neurosci (1993) 0.82
Associations of individual genomic heterozygosity, estimated by molecular fingerprinting, and of dam major histocompatibility complex with growth and egg production traits in layer chickens. Poult Sci (1996) 0.82
A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder. J Affect Disord (1999) 0.81
Venlafaxine in treatment-resistant major depression: a Canadian multicenter, open-label trial. J Clin Psychopharmacol (1999) 0.81
[Mesoridazine therapy in neurotics-clinical trial]. Union Med Can (1972) 0.81
Photophobia in depression. Am J Psychiatry (1989) 0.81
Preparatory brain potentials in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (1991) 0.81
A controlled study of penfluridol in the treatment of chronic schizophrenia. Am J Psychiatry (1978) 0.80
Auditory evoked potentials in panic disorder. J Psychiatry Neurosci (1991) 0.80
Electrophysiological and behavioral correlates of psychomotor responsivity in depression. Biol Psychiatry (1987) 0.80
Psychophysiological correlates of sodium lactate. Psychopharmacol Bull (1984) 0.80
Effects of lactate-induced panic attacks on brain stem auditory evoked potentials. Neuropsychobiology (1986) 0.80
Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder. J Clin Psychopharmacol (1993) 0.79
Diazepam potentiates the effect of neuroleptics on behavioural activity as well as dopamine and norepinephrine turnover: Do benzodiazepines have antipsychotic potency? J Neural Transm (1983) 0.79
Validity and sensitivity of the french version of the Zerssen BfS/BfS' self-rating mood scale during treatment with trazodone and amitriptyline. Prog Neuropsychopharmacol (1981) 0.79
Pimozide and the social behavior of schizophrenics. Curr Ther Res Clin Exp (1975) 0.79
Serologic distinction between human T-lymphotropic virus (HTLV) type I and HTLV type II. Transfusion (1991) 0.79
Clinical and physiological assessment of chlorazepate, diazepam and placebo in anxious neurotics. Int J Clin Pharmacol Biopharm (1975) 0.79
Event-related potentials and selective attention in major depressive illness. J Affect Disord (1991) 0.79
Mianserin kinetics in depressed patients. Clin Pharmacol Ther (1983) 0.78
Neuropsychophysiological correlates of lactate-induced panic. Prog Neuropsychopharmacol Biol Psychiatry (1988) 0.78
Selective dopamine D2 antagonist and prolactin response in acute schizophrenia--results from remoxipride studies. The Canadian Remoxipride Study Group. Prog Neuropsychopharmacol Biol Psychiatry (1990) 0.78
SSRIs in anxious-agitated depression: a post-hoc analysis of 279 patients. Int Clin Psychopharmacol (1995) 0.78
Agitated and retarded depression. A clinical psychophysiological evaluation. Neuropsychobiology (1980) 0.78
Combined SSRI-moclobemide treatment of psychiatric illness. J Clin Psychiatry (1994) 0.78
Effects of cholinergic and GABAergic drugs on apomorphine-induced gnawing behavior in rats. Biol Psychiatry (1982) 0.77
Temporal segmentation of response speed in depression: neuro-electrophysiological approaches. Prog Neuropsychopharmacol Biol Psychiatry (1991) 0.77
Panic induced by sodium lactate: electrophysiological correlates. Prog Neuropsychopharmacol (1981) 0.77
Platelet serotonin measures in primary dysthymia. Am J Psychiatry (1994) 0.77
Brainstem evoked potentials in panic disorder. J Psychiatry Neurosci (1994) 0.77
Synthesis and characterization of an aryl-azidoparoxetine. A novel photo-affinity probe for serotonin-transporter. Biochem Pharmacol (1995) 0.77
A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression. J Affect Disord (1994) 0.77
Thyrotropin releasing hormone: neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines. Psychopharmacology (Berl) (1980) 0.77
Efficacy of lithium in treating mood disorder occurring after brain stem injury. Am J Psychiatry (1981) 0.77
Phenothiazine treatment and electrocardiographic abnormalities. Can Psychiatr Assoc J (1969) 0.76
Effects of short- and long-term neuroleptic treatment on brain serotonin synthesis and turnover: focus on the serotonin hypothesis of schizophrenia. Life Sci (1981) 0.76
Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry (1985) 0.76
Control of lithium tremor with propranolol. Can Med Assoc J (1976) 0.76
Chimeric fibrolase: covalent attachment of an RGD-like peptide to create a potentially more effective thrombolytic agent. Thromb Res (1997) 0.76
Fluvoxamine influences serotonergic system in the brain: neurochemical evidence. Neuropsychobiology (1983) 0.76
Rapid recurrence of mania following lithium withdrawal. Biol Psychiatry (1980) 0.76
Comparison of chlormethiazole (Heminevrin) and chlordiazepoxide (Librium) in the treatment of acute alcohol withdrawal. Neuropsychobiology (1983) 0.76
Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder. Anxiety (1996) 0.76
Quantitative EEG correlates of panic disorder. Psychiatry Res (1996) 0.76
Ethics and placebo. J Psychiatry Neurosci (1998) 0.75
Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies. Clin Neuropharmacol (1993) 0.75